{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:56:01Z","timestamp":1791032161699,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/bf03346392","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T21:44:42Z","timestamp":1396043082000},"page":"463-469","source":"Crossref","is-referenced-by-count":17,"title":["Lessons from second- and third-generation parathyroid hormone assays in primary hyperparathyroidism"],"prefix":"10.1007","volume":"31","author":[{"given":"J. C.","family":"Souberbielle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Boudou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cormier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,27]]},"reference":[{"key":"BF03346392_CR1","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.1658941","volume":"254","author":"H J\u00fcppner","year":"1991","unstructured":"J\u00fcppner H, Abou-Samra AB, Freeman M, et al. A G-protein coupled receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 1991, 254: 1024\u20136.","journal-title":"Science"},{"issue":"suppl3","key":"BF03346392_CR2","first-page":"S1","volume":"42","author":"National Kidney Foundation.","year":"2003","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003, 42(suppl 3): S1\u2013201.","journal-title":"Am J Kidney Dis"},{"key":"BF03346392_CR3","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1210\/jc.2002-020275","volume":"87","author":"C Tannenbaum","year":"2002","unstructured":"Tannenbaum C, Clark J, Schwartzman K, et al. Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 2002, 87: 4431\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346392_CR4","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1210\/jcem-28-7-1037","volume":"28","author":"S Berson","year":"1968","unstructured":"Berson S, Yalow R. Immunochemical heterogeneity of parathyroid hormone in plasma. J Clin Endocrinol Metab 1968, 28: 1037\u201347.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346392_CR5","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/clinchem\/33.8.1364","volume":"33","author":"S Nussbaum","year":"1987","unstructured":"Nussbaum S, Zahradnik R, Lavigne JR, et al. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 1987, 33: 1364\u20137.","journal-title":"Clin Chem"},{"key":"BF03346392_CR6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1210\/jcem-67-2-353","volume":"67","author":"E Blind","year":"1988","unstructured":"Blind E, Schmidt-Gayk H, Scharla S, et al. Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a mid-region assay. J Clin Endocrinol Metab 1988, 67: 353\u201360.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346392_CR7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/clinchem\/37.2.162","volume":"37","author":"DB Endres","year":"1991","unstructured":"Endres DB, Villanueva R, Sharp CF Jr, Singer FR. Immunochemiluminometric and immunoradiometric determinations of intact and total immunoreactive parathyrin: performance in the differential diagnosis of hypercalcemia and hypoparathyroidism. Clin Chem 1991, 37: 162\u20138.","journal-title":"Clin Chem"},{"key":"BF03346392_CR8","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/clinchem\/35.9.1957","volume":"35","author":"W Ratcliffe","year":"1989","unstructured":"Ratcliffe W, Heath DA, Ryan M, Jones SR. Performance and diagnostic application of a two-site immunometric assay for parathyrin in serum. Clin Chem 1989, 35: 1957\u201361.","journal-title":"Clin Chem"},{"key":"BF03346392_CR9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/000456329703400115","volume":"34","author":"VP Michelangeli","year":"1997","unstructured":"Michelangeli VP, Heyma P, Colman PG, Ebeling PR. Evaluation of a new, rapid and automated immunochemiluminometric assay for the measurement of serum intact parathyroid hormone. Ann Clin Biochem 1997, 34: 97\u2013103.","journal-title":"Ann Clin Biochem"},{"key":"BF03346392_CR10","first-page":"131","volume":"48","author":"D Hemsen","year":"2002","unstructured":"Hemsen D, Franzson L, Hoffmann JP, et al. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys system 2010 and 1010. Clin Lab 2002, 48: 131\u201341.","journal-title":"Clin Lab"},{"key":"BF03346392_CR11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/clinchem\/44.4.805","volume":"44","author":"R Lepage","year":"1998","unstructured":"Lepage R, Roy L, Brossard JH, et al. A non-(1-84) circulating parathyroid hormone fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 1998, 44: 805\u20139.","journal-title":"Clin Chem"},{"key":"BF03346392_CR12","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1523-1755.2005.00493.x","volume":"68","author":"P D\u2019Amour","year":"2005","unstructured":"D\u2019Amour P, Brossard JH, Rousseau L, et al. Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism. Kidney Int 2005, 68: 998\u20131007.","journal-title":"Kidney Int"},{"key":"BF03346392_CR13","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1210\/jcem.84.11.6236","volume":"84","author":"MR John","year":"1999","unstructured":"John MR, Goodman WG, Gao P, Cantor TL, Salusky IB, J\u00fcppner H. A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implication for PTH measurements in renal failure. J Clin Endocrinol Metab 1999, 84: 4287\u201390.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346392_CR14","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1359\/jbmr.2001.16.4.605","volume":"16","author":"P Gao","year":"2001","unstructured":"Gao P, Scheibel S, D\u2019Amour P, et al. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1\u201384: implication for improvement of accurate assesment of parathyroid function. J Bone Miner Res 2001, 16: 605\u201314.","journal-title":"J Bone Miner Res"},{"key":"BF03346392_CR15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1373\/clinchem.2003.026831","volume":"50","author":"M Inaba","year":"2004","unstructured":"Inaba M, Nakatsuka K, Imanishi Y, et al. Technical and clinical characterization of the Bio-PTH (1-84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone. Clin Chem 2004, 50: 385\u201390.","journal-title":"Clin Chem"},{"key":"BF03346392_CR16","doi-asserted-by":"crossref","unstructured":"Friedman P. PTH revisited. Kidney Int Suppl 2004, (91): S13\u20139.","DOI":"10.1111\/j.1523-1755.2004.09103.x"},{"key":"BF03346392_CR17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/er.2003-0024","volume":"26","author":"TM Murray","year":"2005","unstructured":"Murray TM, Rao LG, Divieti P, Bringhurst FR. Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological action of carboxyl-terminal ligands. Endocr Rev 2005, 26: 78\u2013113.","journal-title":"Endocr Rev"},{"key":"BF03346392_CR18","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1210\/jc.2002-021370","volume":"87","author":"JP Bilezikian","year":"2002","unstructured":"Bilezikian JP, Potts JT Jr, Fuleihan Gel-H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 2002, 87: 5353\u201361.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346392_CR19","first-page":"173","volume":"28","author":"P Glendenning","year":"1998","unstructured":"Glendenning P, Gutteridge DH, Retallack RW, Stuckey BG, Kermode DG, Kent GN. High prevalence of normal total calcium and intact PTH in 60 patients with proven primary hyperparathyroidism: a challenge to current diagnostic criteria. Aust N Z J Med 1998, 28: 173\u20138.","journal-title":"Aust N Z J Med"},{"key":"BF03346392_CR20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0002-9343(91)90193-2","volume":"91","author":"AN Hollenberg","year":"1991","unstructured":"Hollenberg AN, Arnold A. Hypercalcemia with low-normal serum intact PTH: a novel presentation of primary hyperparathyroidism. Am J Med 1991, 91: 547\u20138.","journal-title":"Am J Med"},{"key":"BF03346392_CR21","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1210\/jc.2003-030097","volume":"88","author":"JC Souberbielle","year":"2003","unstructured":"Souberbielle JC, Lawson-Body E, Hammadi B, Sarfati E, Kahan A, Cormier C. The use in clinical practice of parathyroid hormone normative values established in vitamin D-sufficient subjects. J Clin Endocrinol Metab 2003, 88: 3501\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346392_CR22","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1210\/jc.2003-031014","volume":"88","author":"S Silverberg","year":"2003","unstructured":"Silverberg S, Bilezikian J. \u201cIncipient\u201d primary hyperparathyroidism: a \u201cforme fruste\u201d of an old disease. J Clin Endocrinol Metab 2003, 88: 5348\u201352.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346392_CR23","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1210\/jc.2002-021404","volume":"88","author":"G Maruani","year":"2003","unstructured":"Maruani G, Hertig A, Paillard M, Houillier P. Normocalcemic primary hyperpara-thyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. J Clin Endocrinol Metab 2003, 88: 4641\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346392_CR24","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1210\/jc.2002-021266","volume":"88","author":"S Silverberg","year":"2003","unstructured":"Silverberg S, Gao P, Brown I, LoGerfo P, Cantor TL, Bilezikian JP. Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism. J Clin Endocrinol Metab 2003, 88: 4725\u201330.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346392_CR25","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1373\/clinchem.2003.026328","volume":"50","author":"V Carnevale","year":"2004","unstructured":"Carnevale V, Dionisi S, Nofroni I, et al. Potential utility of a new IRMA for parathyroid hormone in postmenopausal patients with primary hyperparathyroidism. Clin Chem 2004, 50: 626\u201331.","journal-title":"Clin Chem"},{"key":"BF03346392_CR26","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1210\/jc.2005-0715","volume":"90","author":"P Boudou","year":"2005","unstructured":"Boudou P, Ibrahim F, Cormier C, Chabas A, Sarfati E, Souberbielle JC. Third- or second-generation PTH assays: a remaining debate in the diagnosis of primary hyperparathyroidism. J Clin Endocrinol Metab 2005, 90: 6370\u20132.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346392_CR27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.5414\/CNP61337","volume":"61","author":"H Koller","year":"2003","unstructured":"Koller H, Zitt E, Staudacher G, Neyer U, Mayer G, Rosenkranz AR. Variable parathyroid hormone (1-84)\/carboxyl-terminal PTH ratios detected by 4 novel parathyroid hormone assays. Clin Nephrol 2003, 61: 337\u201343.","journal-title":"Clin Nephrol"},{"key":"BF03346392_CR28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.ki.5001606","volume":"70","author":"JC Souberbielle","year":"2006","unstructured":"Souberbielle JC, Boutten A, Carlier MC, et al. Inter-method variability in PTH measurement: implication for the care of CKD patients. Kidney Int 2006, 70: 345\u201350.","journal-title":"Kidney Int"},{"key":"BF03346392_CR29","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1373\/clinchem.2006.071589","volume":"52","author":"T Cantor","year":"2006","unstructured":"Cantor T, Yang Z, Caraiani N, Ilamathi E. Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: implication for treatment decisions. Clin Chem 2006, 52: 1771\u20136.","journal-title":"Clin Chem"},{"key":"BF03346392_CR30","first-page":"3086","volume":"86","author":"JC Souberbielle","year":"2001","unstructured":"Souberbielle JC, Cormier C, Kindermans C, et al. Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab 2001, 86: 3086\u201390.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346392_CR31","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00198-006-0084-3","volume":"17","author":"O Sahota","year":"2006","unstructured":"Sahota O, Mundey MK, San P, Godber IM, Hosking DJ. Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency. Osteoporos Int 2006, 17: 1013\u201321.","journal-title":"Osteoporos Int"},{"key":"BF03346392_CR32","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1172\/JCI111995","volume":"76","author":"NH Bell","year":"1985","unstructured":"Bell NH, Greene A, Epstein S, Oexmann MJ, Shaw S, Shary JR. Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest 1985, 76: 470\u20133.","journal-title":"J Clin Invest"},{"key":"BF03346392_CR33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1210\/jcem-58-2-223","volume":"58","author":"R Marcus","year":"1984","unstructured":"Marcus R, Madvig P, Young G. Age-related changes in parathyroid hormone and parathyroid hormone action in normal humans. J Clin Endocrinol Metab 1984, 58: 223\u201330.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346392_CR34","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1373\/clinchem.2005.060962","volume":"52","author":"P Boudou","year":"2006","unstructured":"Boudou P, Ibrahim F, Cormier C, Sarfati E, Souberbielle JC. Unexpected serum parathyroid hormone profiles in some patients with primary hyperparathyroidism. Clin Chem 2006, 52: 757\u201360.","journal-title":"Clin Chem"},{"key":"BF03346392_CR35","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1373\/clinchem.2003.021592","volume":"49","author":"P D\u2019Amour","year":"2003","unstructured":"D\u2019Amour P, Brossard JH, Rousseau L, Roy L, Gao P, Cantor T. Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH (1-84) is overproduced in primary and secondary hyperparathyroidism. Clin Chem 2003, 49: 2037\u201344.","journal-title":"Clin Chem"},{"key":"BF03346392_CR36","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1016\/S0021-9258(17)43241-8","volume":"259","author":"SA Rabbani","year":"1984","unstructured":"Rabbani SA, Kremer R, Bennett HP, Goltzman D. Phosphorylation of parathyroid hormone by human and bovine parathyroid glands. J Biol Chem 1984, 259: 2949\u201355.","journal-title":"J Biol Chem"},{"issue":"suppl1","key":"BF03346392_CR37","first-page":"S327","volume":"19","author":"M Rubin","year":"2004","unstructured":"Rubin M, D\u2019Amour P, Cantor T, Bilezikian J, Silverberg S. A molecular form of PTH distinct from PTH (1-84) is produced in parathyroid carcinoima. J Bone Miner Res 2004, 19(suppl 1): S327.","journal-title":"J Bone Miner Res"},{"key":"BF03346392_CR38","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2265.2005.02286.x","volume":"62","author":"A R\u00e4kel","year":"2005","unstructured":"R\u00e4kel A, Brossard JH, Patenaude JV, et al. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery. Clinical Endocrinology (Oxf) 2005, 62: 721\u20137.","journal-title":"Clinical Endocrinology (Oxf)"},{"key":"BF03346392_CR39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5414\/CNP64069","volume":"64","author":"M Tanaka","year":"2005","unstructured":"Tanaka M, Itoh K, Matsushita K, Fujii H, Fukagawa M. Normalization of reversed bio-intact-PTH(1-84)\/intact-PTH ratio after parathyroidectomy in a patient with severe secondary hyperparathyroidism. Clin Nephrol 2005, 64: 69\u201372.","journal-title":"Clin Nephrol"},{"key":"BF03346392_CR40","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1210\/jc.2006-0273","volume":"1","author":"F Lafferty","year":"2006","unstructured":"Lafferty F, Hamlin C, Corrado K, Arnold A, Shuck J. Primary hyperparathyroidism with a low-normal atypical serum parathyroid hormone as shown by discordant immunoassay curves. J Clin Endocrinol Metab 2006, 1: 3826\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346392_CR41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cccn.2004.01.024","volume":"343","author":"R Savoca","year":"2004","unstructured":"Savoca R, Bock A, Kraenzlin M, Schmid H, Huber A. An automated \u201cbio-intact\u201d PTH assay: a step towards standardisation and improved correlation with parathyroid function in renal disease. Clin Chim Acta 2004, 343: 167\u201371.","journal-title":"Clin Chim Acta"},{"key":"BF03346392_CR42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00000658-200207000-00016","volume":"236","author":"H Yamashita","year":"2002","unstructured":"Yamashita H, Gao P, Noguchi S, et al. Role of cyclase activating parathyroid hormone (1-84 PTH) measurements during parathyroid surgery: potential improvement of intraoperative PTH assay. Ann Surg 2002, 236: 105\u201311.","journal-title":"Ann Surg"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346392.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03346392\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T06:15:58Z","timestamp":1648707358000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03346392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["BF03346392"],"URL":"https:\/\/doi.org\/10.1007\/bf03346392","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}